BlackRock Advisors’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$2.24M Buy
87,248
+4,824
+6% +$127K ﹤0.01% 1457
2016
Q3
$2.26M Buy
82,424
+872
+1% +$23.9K ﹤0.01% 1413
2016
Q2
$2.3M Buy
81,552
+6,960
+9% +$179K ﹤0.01% 1379
2016
Q1
$1.76M Buy
74,592
+2,324
+3% +$51.2K ﹤0.01% 1479
2015
Q4
$1.63M Buy
72,268
+38,700
+115% +$882K ﹤0.01% 1494
2015
Q3
$776K Buy
33,568
+11,932
+55% +$299K ﹤0.01% 1879
2015
Q2
$533K Buy
21,636
+144
+0.7% +$3.6K ﹤0.01% 2135
2015
Q1
$539K Hold
21,492
﹤0.01% 2021
2014
Q4
$496K Hold
21,492
﹤0.01% 2009
2014
Q3
$503K Hold
21,492
﹤0.01% 1971
2014
Q2
$497K Hold
21,492
﹤0.01% 2023
2014
Q1
$459K Buy
21,492
+1,416
+7% +$31.9K ﹤0.01% 2104
2013
Q4
$475K Buy
20,076
+1,068
+6% +$23.1K ﹤0.01% 2079
2013
Q3
$380K Sell
19,008
-788
-4% -$15K ﹤0.01% 2126
2013
Q2
$342K Buy
+19,796
New +$329K ﹤0.01% 2113

Other funds holding TECH

BlackRock Advisors's TECH Position: Q4 2016 in Review

BlackRock Advisors increased its Bio-Techne (TECH) stake by 5.9% in Q4 2016, buying an estimated $127K and bringing the position to 87,248 shares worth $2.24M. The position accounts for ﹤0.01% of the portfolio, ranked #1457.

BlackRock Advisors first reported a position in TECH in Q2 2013 and has held it in 15 quarters since. The position peaked at $2.3M in Q2 2016. 281 funds tracked by Wall St. Rank hold TECH as of Q4 2016.

  • BlackRock Advisors held 87,248 shares of Bio-Techne worth $2.24M as of Q4 2016.
  • BlackRock Advisors bought 4,824 Bio-Techne shares in Q4 2016, an estimated $127K.
  • Bio-Techne made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1457 holding.
  • BlackRock Advisors first reported a position in Bio-Techne in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Bio-Techne position peaked at $2.3M in Q2 2016.
  • 281 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.